Plasma complement components and activation fragments: Associations with age-related macular degeneration genotypes and phenotypes

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 12, 2009, Pages 5818-5827

  Reynolds, Robyn ^a   Hartnett, M Elizabeth ^b   Atkinson, John P ^c   Giclas, Patricia C ^d   Rosner, Bernard ^e   Seddon, Johanna M ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d DEPARTMENT OF MEDICINE   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT BB; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT CFB; COMPLEMENT COMPONENT SC5B 9; COMPLEMENT FACTOR D; DNA; UNCLASSIFIED DRUG; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ARMS2 PROTEIN, HUMAN; CFI PROTEIN, HUMAN; COMPLEMENT COMPONENT C2; COMPLEMENT FACTOR H; COMPLEMENT FACTOR H, HUMAN; COMPLEMENT FACTOR I; PROTEIN;

ADULT; AGED; ARMS2 GENE; ARTICLE; BODY MASS; C2 GENE; C3 GENE; CFB GENE; CFH GENE; CFI GENE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; FUNCTIONAL GENOMICS; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGISTER; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; COMPLEMENT ALTERNATIVE PATHWAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; METABOLISM; RETINA MACULA DEGENERATION;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; COMPLEMENT C2; COMPLEMENT C3; COMPLEMENT FACTOR B; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT SYSTEM PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMANS; MACULAR DEGENERATION; MALE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS;

EID: 73349112242     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-3928     Document Type: Article

References (41)

1. Gold B, Merriam JE, Zernant J, et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet. 2006;38:458-462.
2. Maller J, George S, Purcell S, et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet. 2006;38: 1055-1059.
3. Hageman GS, Anderson DH, Johnson LV, et al. A common haplo-type in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA. 2005;102:7227-7232.
4. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308: 385-389.
5. Edwards AO, Ritter R, Abel KJ, et al. Complement factor H polymorphism and age related macular degeneration. Science. 2008; 308:421-424.
6. Li M, Atmaca-Sonmez P, Othman M, et al. CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat Genet. 2006;38: 1049-1054.
7. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308:419-421.
8. Maller J, Fagerness J, Reynolds R, et al. Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet. 2007;39:1200-1201.
9. Fagerness JA, Maller J, Neale B, Reynolds R, Daly M, Seddon J. Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet. 2009;17(1):100-104.
10. Jakobsdottir J, Conley Y, Weeks DE, et al. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Gen. 2005;77(3):389-407.
11. Dewan A, Liu M, Hartman S, et al. HTRA1 promoter polymorphism in we age-related macular degeneration. Science. 2006;314:989-992.
12. Yang Z, Camp NJ, Sun H, et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science. 2006;314:992-993.
13. Kanda A, Chen W, Othman M, et al. A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci USA. 2007;104:16227-16232.
14. Seddon JM, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol. 2003;121: 785-792.
15. Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA. 2004;291(6):704-710.
16. Seddon JM, Gensler G, Klein ML, Milton RC. C-reactive protein and homocysteine are associated with dietary and behavioral risk factors for age-related macular degeneration. Nutrition. 2006;22:441-443.
17. Seddon JM, George S, Rosner B, Klein M. CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum Hered. 2006;61:157-165.
18. Seddon JM, Reynolds R, Maller J, Fagerness JA, Daly MJ, Rosner B. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci. 2009;50: 2044-2053.
19. Snow KK, Cote J, Yang W, Davis NJ, Seddon JM. Association between reproductive and hormonal factors and age-related macu-lopathy in postmenopausal women. Am J Ophthalmol. 2002;134: 842-848.
20. Seddon JM, Santangelo SL, Book K, Chong S, Cote J. A genome-wide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. Am J Hum Genet. 2003;73:780-90.
21. Seddon JM, Cote J, Page WF, Aggen SH, Neale MC. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol. 2005;123:321-327.
22. Seddon JM, Sharma S, Adelman R. Evaluation of the clinical age-related maculopathy staging system. Ophthalmology. 2006;113: 260-266.
23. Harbeck RJ, Giclas PC. Diagnostic Immunology Laboratory Manual. New York: Raven Press; 1991.
24. Seddon JM, Francis PJ, George S, Schultz D, Rosner B, Klein M. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA. 2007;297:1793-1800.
25. Lynch AM, Gibbs RS, Murphy JR, et al. Complement activation fragment Bb in early pregnancy and spontaneous preterm birth. Am J Obstet Gynecol. 2008;199(4):354.e1-8.
26. Fang CJ, Richards A, Liszewski MK, Kavanagh D, Atkinson JP. Advances in understanding of pathogenesis of aHUS and HELLP. Br J Haematol. 2008;143:336-348.
27. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001;20(6):705-732.
28. Zhou J, Jang YP, Kim SR, Sparrow JR. Complement activation by photooxidation products of A2E, a liposfuscin constituent of the retinal pigment epithelium. Proc Natl Acad Sci USA. 2006;103(44): 16182-16187.
29. Atkinson JP. Complement System. In: Firestein GS, Budd RC, Harris ED, McInnes IB, Ruddy S, Sergent JS, eds. Kelley's Textbook of Rheumatology. 8th ed. Baltimore: W.B. Saunders Elsevier; 2009; 323-337.
30. Bora NS, Kaliappan S, Jha P, et al. Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: role of factor B and factor H. J Immunol. 2006;177:1872-1878.
31. Bora P, Sohn JH, Cruz JM, et al. Role of complement and complement membrane attack complex in laser: induced choroidal neo-vascularization. J Immunol. 2005;174:491-497.
32. Nozaki M, Raisler BJ, Sakurai E, et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci USA. 2006;103(7):2328-2333.
33. Huber-Lang M, Sarma JV, Zetoune FS, et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med. 2006;12(6):682-687.
34. Scholl HPN, Issa PC, Walier M, Janzer S, et al. Systemic complement activation in age-related macular degeneration. PLOSOne. 2008;3(7):e2593.
35. Pattrick M, Luckett J, Yue L, Stover C. Dual role of complement in adipose tissue. Mol Immunol. 2009;46:755-760.
36. Sivaprasad S, Adewoyin T, Bailey TA, et al. Estimation of systemic complement C3 activity in age-related macular degeneration. Arch Ophthalmol. 2007;125:515-519.
37. White RT, Damm D, Hancock N, et al. Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. Biol Chem, 1992;267(13):9210-9213.
38. Paglialunga S, Fisette A, Yan Y, et al. Acylation: stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice. Am J Endocrinol Metab. 2008;294:E521-E529.
39. Wamba PC, Mi J, Zhao XY, et al. Acylation stimulating protein but not complement C3 associates with metabolic syndrome components in Chinese children and adolescents. Eur J Endocrinol. 2008;159:781-790.
40. Hernandez-Mijares A, Jarabo-Bueno MM, Lopez-Ruiz A, et al. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors. Int J Obes (Lond). 2007;31(6):927-932.
41. Warnberg J, Nova E, Moreno LA, Romeo J, et al. Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study. Am J Clin Nutr. 2006; 84(3):505-512.